Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid for prevention of recurrent choledocholithiasis after endoscopic stone removal
TCTR20231102009Phase 4Unknown
- Sponsor
- Phramongkutklao Hospital
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in choledocholithiasis, sponsored by Phramongkutklao Hospital. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on TCTR20231102009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231102009.